Iodixanol Injection Shortage

• • GE Healthcare has Visipaque presentations available.
  • Fresenius Kabi launched iodixanol in mid-July 2022. The company is marketing and distributing iodixanol for Jiangsu Hergrui Pharmaceuticals in the US.

• • Visipaque solution for injection, GE Healthcare, 270 mg/mL, 100 mL +PLUSPAK bottle, 10 count, NDC 00407-2222-17
  • Visipaque solution for injection, GE Healthcare, 270 mg/mL, 150 mL +PLUSPAK bottle, 10 count, NDC 00407-2222-19
  • Visipaque solution for injection, GE Healthcare, 270 mg/mL, 200 mL +PLUSPAK bottle, 10 count, NDC 00407-2222-21
  • Visipaque solution for injection, GE Healthcare, 270 mg/mL, 50 mL +PLUSPAK bottle, 10 count, NDC 00407-2222-16
  • Visipaque solution for injection, GE Healthcare, 320 mg/mL, 100 mL +PLUSPAK bottle, 10 count, NDC 00407-2223-17
  • Visipaque solution for injection, GE Healthcare, 320 mg/mL, 150 mL +PLUSPAK bottle, 10 count, NDC 00407-2223-19
  • Visipaque solution for injection, GE Healthcare, 320 mg/mL, 200 mL +PLUSPAK bottle, 10 count, NDC 00407-2223-21
  • Visipaque solution for injection, GE Healthcare, 320 mg/mL, 50 mL +PLUSPAK bottle, 10 count, NDC 00407-2223-16
  • Visipaque solution for injection, GE Healthcare, 320 mg/mL, 500 mL +PLUSPAK bottle, 10 count, NDC 00407-2223-23
  • Iodixanol solution for injection, Fresenius Kabi, 270 mg/mL, 100 mL bottle, 10 count, NDC 65219-0381-10
  • Iodixanol solution for injection, Fresenius Kabi, 270 mg/mL, 150 mL bottle, 10 count, NDC 65219-0381-50
  • Iodixanol solution for injection, Fresenius Kabi, 320 mg/mL, 100 mL bottle, 10 count, NDC 65219-0383-10
  • Iodixanol solution for injection, Fresenius Kabi, 320 mg/mL, 150 mL bottle, 10 count, NDC 65219-0383-50
  • Iodixanol solution for injection, Fresenius Kabi, 320 mg/mL, 200 mL bottle, 10 count, NDC 65219-0383-70
  • Iodixanol solution for injection, Fresenius Kabi, 320 mg/mL, 50 mL bottle, 10 count, NDC 65219-0383-05

Estimated Resupply Dates

• • All marketed presentations are available.

Alternative Agents & Management

• • Non-ionic, low osmolality contrast media in current use include iopamidol, iohexol, iopromide, and ioversol.
  • Iodixanol (iso-osmolality agent) is also included in the low osmolality contrast media category.[1]

References

• 1. ACR Manual on Contrast Media. American College of Radiology. https://www.acr.org/-/media/ACR/Files/Clinical-Resources/Contrast_Media.pdf. 2021.